Satsuma Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2022.
  • Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $1.09M, a 11.8% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $5.56M, a 8.28% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.71M, a 6.36% increase from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.36M, a 33.5% increase from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.02M, a 438% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.71M +$341K +6.36% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $5.36M +$1.35M +33.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $4.02M +$3.27M +438% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $747K +$577K +339% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $170K +$104K +158% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $66K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.